Vertebroplasty and Kyphoplasty Market based on Product (Kyphoplasty and Vertebroplasty), End User (Hospitals and Ambulatory Surgical Centers) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2023 - 2028
The Vertebroplasty and Kyphoplasty Market is expected to grow at a rate of 5.5% CAGR by 2028.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023 -2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
5
REPORT DESCRIPTION
Vertebroplasty and kyphoplasty are surgical processes used to treat pain caused by vertebral compression fractures in spine. Vertebral compression fractures caused from condition such as osteoporosis. Vertebroplasty is the procedure of administering cement into the fractured bone with the help of imaging methods whereas kyphoplasty defined as the procedure of injecting cement by creating a cavity with the help of balloon in the fractured bone. This cavity is further filled with cement and therefore, helps in restoration of the fractured bone. There is a surge in adoption of minimally invasive surgeries these days among people. The vertebroplasty and kyphoplasty surgeries are some of the minimally invasive procedures adopted by healthcare providers and patients for viable and efficient management of vertebral column fractures. These techniques provide numerous benefits over the conventional surgeries, such as quick recovery, fewer invasions to the body, less hospital stay, and better preoperative pain management, which results to increase in demand for vertebroplasty and kyphoplasty in the healthcare sector and augment the market growth. On the other hand, the high costs incurred in the treatment may hamper the market growth. The Vertebroplasty and Kyphoplasty Market is expected to grow at a rate of 5.5% CAGR by 2028.
The Vertebroplasty and Kyphoplasty Market has been segmented as below:
Vertebroplasty and Kyphoplasty Market based on Product
Vertebroplasty and Kyphoplasty Market based on End User
Vertebroplasty and Kyphoplasty Market based on Geography
The market based on product is segmented as Kyphoplasty and Vertebroplasty. The Kyphoplasty segment is likely to hold the highest share in the market. The benefits such as better pain relief, minimum complications, and increase in awareness regarding its benefits. Moreover, the kyphoplasty is a modern procedure of spine surgery for fixing vertebral compression fractures caused because of osteoporosis, cancer, etc. Kyphoplasty is same as vertebroplasty.
Based on the end user, the Vertebroplasty and Kyphoplasty market is bifurcated into Hospitals and Ambulatory Surgical Centers. The hospital segment held the significant share in the market. Hospitals are a significant end-user of vertebroplasty and kyphoplasty products, although specialty antibody application is especially used in research and diagnostic procedures. In the U.S., European countries, and other developed countries hospital infrastructure is strong. Thus, the number of surgeries performed in hospitals is more as compared to that in ambulatory surgical centers. Moreover, the high preference of patients for hospitals owing to the availability of all types of treatment, surge in the number of hospital operating rooms, and increase in awareness about various treatments support provided in hospitals for vertebral compression fractures are projected to contribute to the attractiveness of the segment, which enhance the vertebroplasty and kyphoplasty market growth.
In the regional market of vertebroplasty and kyphoplasty, the regions are divided as North America, Europe, Asia Pacific and rest of the world. The North America region has acquired the major share in the market. The major share of the region is ascribed to the recent advances in vertebroplasty and kyphoplasty products, reimbursements and better access to treatment are the key reasons.
Huge number of global manufacturers who have technical expertise and key competencies are undertaking continuous efforts to develop and manufacture new vertebroplasty and kyphoplasty products to attract more customers. Advanced biomaterial based implants providing increased strength and no leaks of cements during fixing in spine fracture are experiencing a substantial surge in demand in developed and developing nations. Affordability, ease of utility, and new are the major factors emphasized upon by product developers in this area to serve the rising demand for inexpensive care among rapidly increasing population affected by spine fracture. Thus, the above mentioned factors are propelling the global growth.
Prominent players operating in the market are Johnson and Johnson (DePuy Synthes), Globus Medical Inc, BPB MEDICA – BIOPSYBELL, Merit Medical Systems Inc., Medtronic plc, Halma plc, Zavation LLC, Seawon Meditech, Joimax GmbH, and Stryker Corporation
As a result, the osteoporosis is a key non-communicable disease and the most usual bone disease, affecting one in three women and one in five men as the age of 50 years across the world. Hence, osteoporosis leads to compression fractures in mass where, the vertebroplasty and kyphoplasty procedures have a significant role in treating.
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Kyphoplasty
5.3. Vertebroplasty
6. End User: Market Size & Analysis
6.1. Overview
6.2. Hospitals
6.3. Ambulatory Surgical Centers
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. Johnson and Johnson (DePuy Synthes)
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Globus Medical Inc
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. BPB MEDICA – BIOPSYBELL
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Merit Medical Systems Inc.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Medtronic plc
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Halma plc
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Zavation LLC
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Seawon Meditech
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Joimax GmbH
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Stryker Corporation
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
The Vertebroplasty and Kyphoplasty Market has been segmented as below:
Vertebroplasty and Kyphoplasty Market based on Product
Vertebroplasty and Kyphoplasty Market based on End User
Vertebroplasty and Kyphoplasty Market based on Geography
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE